Skip to main content
. 2021 Jun 3;6(3):100183. doi: 10.1016/j.esmoop.2021.100183

Figure 1.

Figure 1

A potential treatment approach for advanced medullary thyroid cancer.

EMA, European Medicines Agency; MTC, medullary thyroid cancer; PRRT, peptide receptor radionuclide therapy; SSR, somatostatin receptor.